Y Fuchimoto
Overview
Explore the profile of Y Fuchimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishiyama R, Shinoda M, Tanabe M, Oshima G, Takano K, Miyasho T, et al.
Eur Surg Res
. 2014 Jan;
51(3-4):181-90.
PMID: 24434684
Background: High-mobility group box chromosomal protein 1 (HMGB1) has recently been identified as an important mediator of various kinds of acute and chronic inflammation. A method for efficiently removing HMGB1...
2.
Tanaka H, Arai K, Fujino A, Takeda N, Watanabe T, Fuchimoto Y, et al.
J Wound Care
. 2013 Jan;
22(1):17-8, 20.
PMID: 23299353
Objective: To estimate the efficacy of sprinkling salt treatment (SS) of hypergranulation at gastrostomy sites in paediatric patients. Method: A prospective case-series study of paediatric patients with hypergranulation at gastrostomy...
3.
Shinoda M, Tanabe M, Kawachi S, Ono Y, Hayakawa T, Iketani O, et al.
Transplant Proc
. 2012 Jun;
44(5):1329-35.
PMID: 22664010
We investigated the pharmacokinetics of mizoribine in the acute phase after adult living donor liver transplantation (LDLT). Between February 2004 and October 2009, 16 recipients received immunosuppressive therapy that included...
4.
Ohdan H, Zhou W, Tanaka Y, Irei T, Fuchimoto Y, Egawa H, et al.
Am J Transplant
. 2007 Jul;
7(9):2190-4.
PMID: 17640317
In a 12-year-old patient with blood group O, who had received a partial liver graft 10 years ago from his father with blood group A, the levels of anti-A-specific antibodies...
5.
Hasegawa Y, Kawachi S, Shimazu M, Hoshino K, Tanabe M, Fuchimoto Y, et al.
Am J Transplant
. 2007 Jul;
7(9):2204-7.
PMID: 17614979
Liver transplantation is the only curative treatment known to date for end-stage liver disease occurring as a result of primary sclerosing cholangitis (PSC). Here, we report a case in which...
6.
Gargollo P, Yamada K, Esnaola N, Fuchimoto Y, Newell K, Sachs D, et al.
Transplantation
. 2001 Sep;
72(5):818-22.
PMID: 11571443
Background: Effective in vivo T-cell depletion is a critical component of many transplantation tolerance protocols. We have previously demonstrated T-cell depletion in miniature swine using a CRM9-based CD3-immunotoxin, pCD3-CRM9. CRM9...
7.
Kunisaki S, Haller G, Fuchimoto Y, Huang C, Sachs D
Transplantation
. 2001 Aug;
72(3):523-6.
PMID: 11502986
Background: Despite the presence of circulating donor-derived T cells during the induction of mixed chimerism across MHC barriers in miniature swine, severe graft-versus-host disease was avoided in the majority of...
8.
Fuchimoto Y, Gleit Z, Huang C, Kitamura H, Schwarze M, Menard M, et al.
Transplantation
. 2001 Jul;
72(1):122-6.
PMID: 11468546
Background: The acceptance of skin allografts has historically been among the most challenging problems in the field of transplantation, attributed, at least in part, to the existence of antigens expressed...
9.
Fuchimoto Y, Huang C, Gleit Z, Kitamura H, Griesemer A, Melendy E, et al.
Transplant Proc
. 2001 Mar;
33(1-2):118-9.
PMID: 11266736
No abstract available.
10.
Fuchimoto Y, Huang C, Yamada K, Gleit Z, Kitamura H, Griesemer A, et al.
Transplant Proc
. 2001 Mar;
33(1-2):77.
PMID: 11266710
No abstract available.